Department of Radiation Oncology, Wake Forest University, Winston-Salem, North Carolina, USA.
J Neurosurg. 2011 Jun;114(6):1585-91. doi: 10.3171/2010.11.JNS10939. Epub 2010 Dec 17.
As a strategy to delay or avoid whole-brain radiotherapy (WBRT) after resection of a brain metastasis, the authors used high-resolution MR imaging and cavity-directed radiosurgery for the detection and treatment of further metastases.
Between April 2001 and October 2009, 112 resection cavities in 106 patients with no prior WBRT were treated using radiosurgery directed to the tumor cavity and for any synchronous brain metastases detected on high-resolution MR imaging at the time of radiosurgical planning. A median dose of 17 Gy to the 50% isodose line was prescribed to the gross tumor volume, defined as the rim of enhancement around the resection cavity. Patients were followed up via serial imaging, and new brain metastases were generally treated using additional radiosurgery, with salvage WBRT typically reserved for local treatment failure at a resection cavity, numerous failures, or failures occurring at short time intervals. Local and distant treatment failures were determined based on imaging results. Kaplan-Meier curves were generated to estimate local and distant treatment failure rates, overall survival, neurological cause-specific survival, and time delay to salvage WBRT.
Radiosurgery was delivered to the resection cavity alone in 57.5% of patients, whereas 24.5% of patients also received treatment for 1 synchronous metastasis, 11.3% also received treatment for 2 synchronous metastases, and 6.6% also received treatment for 3-10 additional lesions. The median overall survival was 10.9 months. Overall survival at 1 year was 46.8%. The local tumor control rate at 1 year was 80.3%. The disease control rate in distant regions of the brain at 1 year was 35.4%, with a median time of 6.9 months to distant failure. Thirty-nine of 106 patients eventually received salvage WBRT, and the median time to salvage WBRT was 12.6 months. Kaplan-Meier estimates showed that the rate of requisite WBRT at 1 year was 45.9%. Neurological cause-specific survival at 1 year was 50.1%. Leptomeningeal failure occurred in 8 patients. One patient had treatment failure within the resection tract. Seven patients required reoperation: 2 for resection cavity recurrence, 3 for radiation necrosis, 1 for hydrocephalus, and 1 for a CSF cutaneous fistula. On multivariate analysis, a preoperative tumor diameter > 3 cm was predictive of local treatment failure.
Cavity-directed radiosurgery combined with high-resolution MR imaging detection and radiosurgical treatment of synchronous brain metastases is an effective strategy for delaying and even foregoing WBRT in most patients. This technique provides acceptable local disease control, although distant treatment failure remains significant.
作为一种延迟或避免脑转移切除术后全脑放疗(WBRT)的策略,作者使用高分辨率磁共振成像和瘤腔定向放射外科来检测和治疗进一步的转移病灶。
2001 年 4 月至 2009 年 10 月,106 例无 WBRT 既往史的患者共 112 个瘤腔,采用放射外科治疗瘤腔和在放射外科计划时高分辨率磁共振成像上检测到的任何同步脑转移病灶。对大体肿瘤体积(定义为瘤腔周围增强的边缘)给予 17Gy 的 50%等剂量线。通过连续影像学检查对患者进行随访,通常使用额外的放射外科治疗新的脑转移病灶,局部治疗失败、大量转移灶或转移灶出现时间间隔较短时,通常保留挽救性 WBRT。根据影像学结果确定局部和远处治疗失败。通过 Kaplan-Meier 曲线估计局部和远处治疗失败率、总生存率、神经原因特异性生存率以及挽救性 WBRT 的时间延迟。
57.5%的患者单独接受了放射外科治疗瘤腔,24.5%的患者还接受了 1 个同步转移灶的治疗,11.3%的患者还接受了 2 个同步转移灶的治疗,6.6%的患者还接受了 3-10 个额外病灶的治疗。中位总生存期为 10.9 个月。1 年总生存率为 46.8%。1 年局部肿瘤控制率为 80.3%。1 年时脑内远处病灶的疾病控制率为 35.4%,远处失败的中位时间为 6.9 个月。106 例患者中有 39 例最终接受了挽救性 WBRT,挽救性 WBRT 的中位时间为 12.6 个月。Kaplan-Meier 估计显示,1 年内需要 WBRT 的比例为 45.9%。1 年时神经原因特异性生存率为 50.1%。8 例患者发生软脑膜失败。1 例患者在瘤腔范围内出现治疗失败。7 例患者需要再次手术:2 例因瘤腔复发,3 例因放射性坏死,1 例因脑积水,1 例因 CSF 皮肤瘘。多因素分析显示,术前肿瘤直径>3cm 是局部治疗失败的预测因素。
瘤腔定向放射外科联合高分辨率磁共振成像检测和同步脑转移的放射外科治疗是一种在大多数患者中延迟甚至避免 WBRT 的有效策略。该技术提供了可接受的局部疾病控制,但远处治疗失败仍然显著。